Overview
Peapod Bio is a Chicago-based contract research organization (CRO) specializing in small molecule drug discovery services. They provide assay development, high-throughput screening (HTS), and hit-to-lead solutions using innovative label-free mass spectrometry, fluorescence, HTRF, AlphaLISA, and optical technologies. Their tailored biochemical and binding assays support pharmaceutical R&D from early-stage screening to lead optimization.
Frequently asked questions
- What drug discovery services does Peapod Bio offer?
- Peapod Bio offers assay development, high-throughput screening (HTS), and hit-to-lead biochemical and binding assays for small molecule drug discovery using label-free mass spectrometry and optical technologies.
- What technologies does Peapod Bio use for assays?
- They utilize MALDI mass spectrometry for label-free assays, along with fluorescence, HTRF, AlphaLISA, and other optical solutions for high-throughput screening and assay development.
- Where is Peapod Bio located and who leads the company?
- Peapod Bio is based in Chicago and led by Founder and CEO Zachary Gurard-Levin, contactable at [email protected] or 312-235-3720 for partnerships.